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Abstract
Introduction In critically ill patients, delirium is a serious and 
frequent disorder that is associated with a prolonged intensive 
care and hospital stay and an increased morbidity and mortality. 
Without the use of a delirium screening instrument, delirium is 
often missed by ICU nurses and physicians. The effects of 
implementation of a screening method on haloperidol use is not 
known. The purpose of this study was to evaluate the 
implementation of the confusion assessment method-ICU 
(CAM-ICU) and the effect of its use on frequency and duration 
of haloperidol use.
Methods We used a tailored implementation strategy focused 
on potential barriers. We measured CAM-ICU compliance, 
interrater reliability, and delirium knowledge, and compared the 
haloperidol use, as a proxy for delirium incidence, before and 
after the implementation of the CAM-ICU.
Results Compliance and delirium knowledge increased from 
77% to 92% and from 6.2 to 7.4, respectively (both, P <  
0.0001). The interrater reliability increased from 0.78 to 0.89. 
More patients were treated with haloperidol (9.9% to 14.8%, P
<  0.001), however with a lower dose (18 to 6 mg, P =  0.01) and 
for a shorter time period (5 [IQR:2-9] to 3 [IQR:1—5] days, P =  
0.02).
Conclusions With a tailored implementation strategy, a delirium 
assessment tool was successfully introduced in the ICU with the 
main goals achieved within four months. Early detection of 
delirium in critically ill patients increases the number of patients 
that receive treatment with haloperidol, however with a lower 
dose and for a shorter time period.
Introduction
Delirium is a common psychiatric disorder in critically ill 
patients. It has an acute onset and combines cognitive and 
attention defects with a fluctuating consciousness [1 ]. It is 
associated with a prolonged intensive care and hospital stay 
and an increased morbidity and mortality [2-4].
Although there has been increasing interest in delirium in the 
past five years, standard screening of patients in daily practice 
is still not common, resulting in an underestimation of the prob­
lem. Previous studies showed that, without the use of a
screening instrument, more than 60% of patients with delirium 
are missed by ICU nurses and more than 70% by physicians 
[5,6]. It can therefore be assumed that delirious patients are 
not sufficiently treated if they are not recognized. The inci­
dence rate in critically ill patients varies between 11% and 
87%, depending on the study design, methods for assess­
ment, and differences in population [2,4,7-9].
Although there is no evidence that the use of a delirium 
assessment tool results in improvement of outcome, early rec­
ognition of delirium is important for adequate and early treat­
APACHE-II: acute physiology and chronic health evaluation-II; CAM-ICU: confusion assessment method-intensive care unit; CI: confidence interval; 
ICDSC: intensive care delirium screening checklist; IQR: inter quartile range.
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ment. Therefore routine screening of patients is necessary. In 
addition, because of the fluctuating clinical signs and symp­
toms of delirium, screening should be performed at least once 
every 8 to 12 hours [10,11]. A delirium assessment tool 
should therefore be quick and easy to use with a high interrater 
reliability.
The Dutch guidelines Delirium in the Intensive Care recom­
mends the screening of all ICU patients with a reliable and val­
idated delirium screening instrument (van Eijk MJJ, Spronk PE, 
van den Boogaard MHWA, Kuiper MA, Smit EGM, Slooter 
AJC. Delirium op de Intensive Care, unpublished data), such 
as the intensive care delirium screening checklist (ICDSC)
[12] or the confusion assessment method-ICU (CAM-ICU)
[13].
The treatment of delirium is based on removing the underlying 
somatic disorder frequently combined with pharmacological 
therapy. Although there is no clear evidence that treatment 
improves the prognosis of delirious ICU patients [14], and 
haloperidol has significant side effects [15,16], haloperidol is 
the most commonly recommended pharmacological agent 
[17]. As screening will probably increase the number of 
patients diagnosed with delirium, it could also increase the use 
of haloperidol. In view of this, it is important to determine the 
effect of the implementation of a screening instrument on the 
use of haloperidol.
The first aim of our study was to evaluate our strategy for the 
implementation of the CAM-ICU. Therefore, the compliance 
with scoring of the CAM-ICU, the interrater reliability, and 
improvement in delirium knowledge of the nurses were used 
as indicators for successful implementation. We assumed that 
a larger number of delirious patients would be detected with 
the use of the CAM-ICU, in comparison with previous periods 
without the standard use of a screening tool. The second aim 
of our study was therefore to assess how the CAM-ICU influ­
ences the frequency and duration of haloperidol use, which 
may be considered to be a proxy for the delirium incidence and 
duration.
Materials and methods
This study was conducted in the Radboud University 
Nijmegen Medical Centre, the Netherlands, a 960-bed univer­
sity hospital that includes a level 3  (highest level) ICU with 40 
beds divided over four adult wards and one paediatric ward. 
Annually 2000 to 2500 (cardiothoracic surgery, neurosurgical, 
medical, surgical, and trauma) patients are admitted.
The local Institutional Review Board of Arnhem-Nijmegen indi­
cated that for this study no approval was required and no 
informed consent from patients was needed.
Nurses and the implementation of the CAM-ICU
Although the ICDSC and the CAM-ICU are suitable delirium 
screening instruments, we preferred to implement the CAM- 
ICU above the ICDSC because of the higher sensitivity and 
specificity, and because the CAM-ICU is translated and vali­
dated in Dutch [18]. The CAM-ICU is an easy to perform 
assessment tool for ICU nurses, which consists of a two-step 
approach model [13] [see Additional data file 1]. Before the 
implementation of the CAM-ICU, identification of delirious 
patients was based on the judgement of the attending ICU 
physician, and a delirium screening instrument was not used. 
Due to the potential importance of unrecognised delirium, we 
decided that this should be changed to a situation where reg­
ular and systematic assessment of delirium was performed by 
ICU nurses with specific knowledge of delirium recognition. 
Therefore, we introduced the CAM-ICU as an instrument for 
early recognition of delirium and started with the implementa­
tion on all four adult ICU wards in December 2007.
Implementation of a delirium assessment tool in daily practice 
introduces an essential change for ICU nurses. As there is no 
single best method for implementing an innovation in all set­
tings [19], it is important to identify potential barriers and facil­
itators in this particular setting. For a good adaptation of a 
delirium screening instrument it is important to tailor the imple­
mentation strategy to these facilitators and barriers [20]. Fur­
thermore, support from the organisation and medical and 
nursing staff participation is important for a successful imple­
mentation [21].
Our implementation strategy [see Additional data file 2] was 
focused on potential barriers and facilitators for screening with 
the CAM-ICU (Table 1), which were identified during several, 
unstructured, interviews with the nursing and medical staff.
We integrated the CAM-ICU algorithm in our patient data 
management system, which is available at all bedside comput­
ers. Because of the fluctuating course of delirium every patient 
had to be assessed minimally once in every eight-hour shift, 
according to the CAM-ICU manual [22]. If the mental status 
changed after an assessment, an additional assessment had 
to be performed. Patients were excluded from screening when 
they had a Richmond agitation sedation score of -4 or -5 [13], 
were unable to understand Dutch, were severely mentally dis­
abled, or suffered from a serious receptive aphasia. All neces­
sary testing tools (attention screening pictures and 
disorganized thinking questions) were made available at every 
bed. The computer notified the nurse about the outcome of the 
CAM-ICU screening, that is, delirious or not.
Evidence-based interventions [23] included in the implemen­
tation strategy were: education; educational outreach visits; 
reminders and feedback; and leadership.
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Table  1
Id e n tifie d  p o te n tia l ba rrie rs  and fa c ilita to rs  d u ring  in te rv iew s
Im plem entation barriers Im plem entation facilitators
1. Lack of knowledge concerning delirium 1. Patient data management system
2. Inavailability of the assessment tool 2. Senior nurses
3. To fill in the delirium assessment tool on paper three times a day ('paperwork') 3. Support of medical and nursing staff
4. Time to perform the assessment 4. Delirium researcher
Education and educational outreach visits
All ICU nurses were trained in the use of the CAM-ICU and 
performed a knowledge test prior to the training. The educa­
tion consisted of a one-hour group training prior to the imple­
mentation of the CAM-ICU. During this training, information 
about delirium features, recognition, and delirium types was 
given. Furthermore, specific information was given about the 
CAM-ICU. We used educational material from the delirium 
website [22] such as the training video and the Harvard CAM- 
ICU flow sheet. W e appointed 'delirium key-nurses', who 
received supplementary training, for further instruction and 
introduction of the CAM-ICU in their unit. In addition, posters 
with the Harvard CAM-ICU flow sheet were distributed to 
nurses and the medical staff. Also, the medical staff was 
informed about delirium and the CAM-ICU. Supplementary 
individual training on the job (by MvdB, and the 'delirium key­
nurses') started one month after the implementation and was 
given whenever screening compliance and interrater reliability 
dropped below the stated aim. The focus during this training 
on the job was on the most common mismatches, that is fea­
ture 1A and 1B [see Additional data file 1]. Determination of 
the presence of cognitive function disturbances and the fluc­
tuating nature of consciousness were the most difficult points 
for the ICU nurses. Individual problems with the assessment 
were addressed by focusing the training on the difficulties 
experienced during observations.
Reminders and feedback
When a delirium assessment was not carried out, a pop-up 
appeared on the bedside computer as a reminder for the 
nurse. The CAM-ICU scoring rate, that is the screening com­
pliance, and the interrater reliability were measured. The 
results were evaluated with the delirium key-nurses and the 
nursing staff, twice a week as parameters of a successful 
implementation. Feedback about results and performance of 
the CAM-ICU was supplied weekly by e-mail and during 
monthly clinical meetings.
Leadership
The medical and nursing staff committed themselves to, and 
supported the implementation of the delirium assessment tool, 
as agreed upon during the information meeting and was 
reported during feedback of the key nurses. One project 
leader was responsible and supervised the implementation
process (MvdB). Prior to the implementation, the CAM-ICU 
was introduced to the medical staff. Two months after the 
implementation, the presence of delirium became a standard 
part of the daily multidisciplinary meeting, in which all patients 
are discussed. All ICU wards were visited daily by the project 
leader to identify problems concerning the performance and 
compliance of the assessment tool and for personal or group 
feedback.
Chosen indicators of a successful implementation were: regu­
lar assessment of all ICU patients defined as a screening com­
pliance of more than 80%; interrater reliability score of more 
than 0.80; and improvement of the level of knowledge con­
cerning delirium.
The compliance was calculated as the percentage of per­
formed assessments per day of the total number of assess­
ments that should have been performed. Interrater reliability 
tests were performed several times during the first month after 
the implementation and twice a week during and after the 
training on the job period. For this the CAM-ICU score 
assessed by the ICU nurse was compared with the CAM-ICU 
score assessed by an expert psychiatric nurse (GR). The max­
imum period between the two assessments was one hour and 
patients were chosen randomly. Patients who were excluded 
from screening with the CAM-ICU were also excluded from the 
interrater reliability testing.
We developed a non-validated written delirium knowledge test 
that had to be completed in 10 minutes prior to the delirium 
training and consisted of 10 mixed open and closed ques­
tions. A similar post-training test was performed four months 
later. 'Delirium knowledge' is expressed on a scale of 0 to 10. 
The implementation period started in December 2007 and 
ended in March 2008, after reaching the indicators of care 
improvement (Figure 1). The nursing staff consists of 140 
nurses of which 18 (13%) were ICU nurses in training.
The patients and haloperidol treatment
As delirium incidence rates before the use of the assessment 
tool were not available, we used the frequency of haloperidol 
use as a proxy for delirium incidence. Data of all patients who 
were treated with haloperidol are available through our patient 
data management system. As a general rule, in our ICU all
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F igure  1
Implementation flow chart. CAM-ICU =  confusion assessment method-intensive care unit.
patients diagnosed with delirium are treated with haloperidol 
and delirium is the only reason for prescribing haloperidol. The 
duration of haloperidol treatment was used as a proxy for the 
duration of the delirious period. For the incidence rate of a 
four-month period (March until June 2008) after the implemen­
tation, the CAM-ICU results were compared with the haloperi­
dol use during the same period of the two previous years. We 
compared the total number of all consecutive patients treated 
with haloperidol, total days of treatment, and the total dose of 
administered haloperidol per patient and per day.
Statistical analyses
All data analyses were performed with SPSS 16.0 (SPSS Inc., 
Chicago, IL, USA). Normally distributed data (demographic 
data, knowledge level, and the scorings rate) were tested par­
ametrically (Student's t-test, repeated measurement analysis 
of variance). Data concerning the treatment with haloperidol 
were not normally distributed and were tested non-parametri- 
cally with the Friedman test and the Kruskal-Wallis one-way 
analysis of variance test. Interrater reliability of the outcome of 
screening, that is delirious or non-delirious, was calculated 
with the Cohen's Kappa statistic.
Results
Evaluation of implementation and nurses
In the first month of the implementation period the interrater 
reliability was 0.78 (n =  25, 95% confidence interval (CI): 0.5 
to 1.0) and following intensive training on the job of almost all 
ICU nurses this increased to 0.89 (n =  47, 95%CI: 0.75 to 
1.0).
In the first month after the implementation the compliance of 
screening with the CAM-ICU was 77% and increased signifi­
cantly to 92% (repeated measurement analysis of variance, P
<  0.0001) after four months. Scoring rate of the nurses at the 
pre-course delirium knowledge test was 6.2 ±  1.7 (n =  136) 
and increased significantly to 7.4 ±  1.2 (n =  122) four months 
later (Student's t-test, P  =  0.0001).
Haloperidol treatment and patients
W ith the exception of a small, but statistically significant differ­
ence in the Acute Physiology and Chronic Health Evaluation-II 
(APACHE-II) score, the demographic variables of the patients 
did not differ between the three years (Table 2). In the same 
period in 2006 and 2007, 13 (10%) and 20 (13%) patients 
per month were treated with haloperidol, respectively (Table 
3). Following the implementation period, based on the CAM- 
ICU results, this increased significantly to 37 (23%) patients 
per month (P <  0.001) compared with the previous period 
without the use of the CAM-ICU. All patients who received 
haloperidol in the period after the implementation in 2008 
were detected with the CAM-ICU as delirious patients. From 
these 147 delirious patients, 25 (17%) had a hyperactive type, 
47 (32%) a hypoactive type, and 74 patients (50.3%) had a 
mixed-type delirium. During this period 641 patients were 
admitted of which 74 patients were excluded from CAM-ICU 
screening. The most frequent reason was sustained coma 
(49%). To compare the effect on the detected incidence 
before and after the implementation of the CAM-ICU, we used 
the total of 641 patients, because of the lack of information of 
the patients in the period before the implementation.
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Table  2
D em ograph ic  va riab les  o f IC U -patien ts b e fo re  and a fte r im p le m e n ta tio n  o f CAM-ICU
Period Prior to implementation 
March to June 2006
Prior to implementation 
March to June 2007
After implementation March to June 
2008
P  value
Number of patients 512 589 641
Age 57.5 ±  16.4 58.9 ±  16.6 59.5 ±  15.6 N.S.
Gender (M/F) 339/173 370/219 409/232 N.S.
APACHE-II score 16.9 ±  7.0 17.1 ±  6.9 15.5 ±  6.5 0.0001
Length of stay on ICU in days (median 
(IQR))
1.3 (0.8 to 5.9) 1.0 (1 to 5) 1.0 (1 to 3) N.S.
Admission type (n)
Elective surgery 214 (42%) 283 (48%) 340 (53%) N.S.
'Urgent surgery 106 (20%) 96 (16%) 76 (12%)
Medical 192 (38%) 210 (36%) 225 (35%)
All values are means ±  standard deviation unless otherwise reported.
APACHE II =  Acute Physiology and Chronic Health Evaluation II; CAM-ICU =  confusion assessment method-intensive care unit; F =  female; ICU 
=  intensive care unit; IQR =  interquartile range; M =  male; N.S. =  non-significant.
The median duration of treatment with haloperidol decreased 
from five (interquartile range (IQR) 2 to 9) to three days (IQR
1 to 5) after the implementation of the CAM-ICU (P =  0.02). 
The median total haloperidol dose per patient (during treat­
ment) decreased from 18 mg (IQR 5 to 39.5) to 6 mg (IQR 2 
to 19.5; P  =  0.01).
Discussion
In a relatively short period of four months, we successfully 
implemented a validated delirium assessment tool in our daily 
practice on the ICU. Following the implementation of the 
CAM-ICU, more patients were treated with haloperidol, but 
with a lower dose and for a shorter period of time when com­
pared with the same period in the two previous years. Almost 
two times more delirious patients were detected with the use 
of the CAM-ICU. Our results indicate that successful imple­
mentation of the CAM-ICU is possible and, importantly, that 
this results in shorter and lower dosed haloperidol treatment.
The implementation of the CAM-ICU
We feel that several aspects of our implementation strategy 
are responsible for this success. First, we used a multifaceted 
model with evidence-based interventions. Although we did not 
measure the effect of the separate interventions, previous 
studies showed that education and feedback with reminders 
are very effective interventions [23]. Second, it is important to 
focus the implementation strategy on potential barriers that 
can be expected in daily practice [19], which will differ from 
hospital to hospital and from ward to ward. W e therefore gath­
ered information about these potential barriers prior to the 
actual implementation. Based on this information, we used the 
facilitators of our organization and integrated the CAM-ICU in 
our patient data management system. Although it took some 
time to develop the integrated CAM-ICU, it was easier to use 
and included a reminder when the assessment had not been 
performed at the end of the shift. The key-nurses played an 
important role in supporting the group and therefore were piv­
otal. They were also particularly helpful in bedside training of 
the ICU nurses, their direct colleagues.
Table  3
E ffect o f th e  im p le m e n ta tio n  o f th e  CAM-ICU in 2008 on de lir iu m  trea tm e n t
2006 
(n =  512)
2007 
(n =  589)
2008 
(n =  641)
P  value
Total numbers of delirious patients (%) 51 (10%) 79 (13%) 147 (23%) <  0.0001
Number of delirious patients per month 13 20 37 <  0.0001
Total dose of haloperidol per patient (mg) 
n =  total number of patients treated with haloperidol
18 (5 to 40) 
(n =  52)
12.5 (3 to 30) 
(n =  80)
6 (2 to 20) 
(n =  1 47)
0.01
Duration of treatment (days) 5 (2 to 9) 3 (2 to 9) 3 (1 to 5) 0.02
All values are medians (interquartile range) unless other reported. CAM-ICU =  confusion assessment method-intensive care unit.
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A final point of interest is the cooperation with the medical 
staff. We noticed that it is important that the CAM-ICU score 
is part of the daily evaluation of the patient and that it is also 
important to react adequately to a positive delirious score by 
treating the patient. Therefore, it is also important to inform the 
medical staff during the implementation (education) and give 
them regular feedback on the results of the implementation 
(compliance, interrater reliability, and delirium knowledge 
level). As these interventions are tailored to the barriers found 
in this study they should not be used as a blueprint for imple­
mentation but could serve as a guideline.
Although the CAM-ICU appears to be relatively simple to use 
and a relatively short training period should result in a reliable 
performance of the CAM-ICU [11,13], our study demonstrates 
that an intensive implementation strategy results in a further 
improvement of its performance. W e aimed for a group inter­
rater reliability score of at least 0.8, which can be considered 
a desirable [24] and attainable goal for the CAM-ICU [13]. Evi­
dently, it is of utmost importance to test the reliability of the 
assessment by the ICU nurses, because a false-positive diag­
nosis may result in unnecessary treatment and vice versa. 
Therefore, in our view, it is necessary to perform interrater reli­
ability tests and analyse the mismatches to be able to give 
adequate feedback. Unfortunately, and surprisingly, not much 
attention is given to this aspect in the literature and many new 
screening and treatment policies appear to be implemented 
without it.
Although a high interrater reliability is important for the per­
formance of the CAM-ICU, a screening tool will only be effec­
tive when the compliance with its use is also high. Although we 
did not formally measure the nursing workload, it is clear that 
the screening of patients with the CAM-ICU results in some 
additional work for the nurses. Our experience is that the mean 
screening time of the patients with the CAM-ICU is two to five 
minutes, which is comparable with that mentioned by Ely and 
colleagues [13]. Based on a study by Soja and colleagues 
[25] we chose an 80% compliance with the CAM-ICU as a 
feasible and acceptable aim for a successful implementation. 
Scoring all patients three times a day during their whole stay 
on the ICU is hardly realistic. Moreover, an optimal compliance 
is unknown. We are convinced that the intensive feedback and 
support of the project leader and the medical and nursing staff 
played an important role in achieving a high compliance.
Haloperidol treatment and patients
One could argue that haloperidol use is not a good proxy for 
the incidence of delirium because it is also used to treat other 
disorders such as serious psychoses, severe excitement, and 
anxiety [26]. However, these disorders are rarely observed in 
our ICU or not treated with haloperidol. In the case of agitation 
in patients without a protected airway we use a low dose of 
propofol, if necessary in combination with oxazepam. There­
fore we are confident that in our ICU only delirious patients are
treated with haloperidol and that the observed difference in 
haloperidol use between the compared treatment periods can 
only be attributed to differences in delirium detection rate.
Despite the fact that we found a higher incidence of delirious 
patients with the CAM-ICU than without the use of a screening 
instrument, the incidence in our population is low. A possible 
explanation is that the study was performed in all consecutive 
patients, with no selection of high-risk patient groups. Includ­
ing patients that were admitted to our ICU following elective 
surgery may also partly explain why the APACHE II score is 
lower compared with other studies that reported higher 
APACHE II scores associated with a higher incidence of delir­
ium [13,27,28].
It is assumed that the regular use of a delirium assessment tool 
results in a higher detection rate of delirious patients, espe­
cially patients with a hypoactive delirium. Naturally, this could 
result in more haloperidol use. Given the potential side effects 
of the drug, the absence of clear evidence that presence of 
hypoactive delirium is associated with poor patient outcome 
and that the use of a delirium assessment tool improves the 
outcome of the ICU patient, one might argue that an increase 
in haloperidol use is not desirable. On the other hand, an ear­
lier and improved recognition of delirious patients may make it 
easier to treat the delirium with lower doses of haloperidol. To 
our knowledge, the influence of performing the CAM-ICU on 
the total amount of haloperidol used per patient has not been 
studied before. It appears plausible that, besides the earlier 
detection of delirious patients, also recovery from the delirious 
period could be detected earlier with the use of a delirium 
assessment tool. As a result, haloperidol treatment would be 
stopped earlier. Our data confirm these assumptions. It is also 
possible that the early treatment of delirium could result in 
shortening of the delirious period, but this assumption needs 
further study.
Conclusions
Tailoring our implementation strategy to the needs of the ICU 
was successful. The main goals were achieved within a rela­
tively short time. Early recognition of delirium with the CAM- 
ICU has become a standard component of daily care by the 
nurses in our ICU and contributes to the quality of care. In 
addition, early detection of delirium leads to lower dosage and 
shorter periods of haloperidol treatment in critically ill patients.
Key messages
• Implementation of the CAM-ICU is feasible and results 
in a higher determination rate of delirium.
• When the CAM-ICU is used, more patients receive 
haloperidol, but in a lower dose and for a shorter period 
of time.
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Additional data file 2
W ord file containing a table that lists the implementation 
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